ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Avoiding Sexual Dysfunction in BPH Surgery
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 157711" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">Abstract </span></strong></p><p></p><p><strong>Purpose of Review </strong></p><p>To review the prevalence and risks of sexual dysfunction associated with current treatment options for benign prostatic hyperplasia and to characterize techniques and methods to manage postoperative sexual dysfunction related side effects.</p><p></p><p><strong>Recent Findings </strong></p><p>Current surgical therapies available for the treatment of benign prostatic hyperplasia are associated with a substantial risk of both ejaculatory and erectile function. However, many of the novel minimally invasive treatment alternatives have demonstrated the ability to preserve postoperative sexual function to a better degree, all while providing significant relief of lower urinary tract symptoms in an equally safe and efficacious manner.</p><p></p><p><strong>Summary </strong></p><p><span style="color: rgb(184, 49, 47)"><strong>Benign prostatic hyperplasia remains a highly prevalent disease among the aging population. While surgical treatments are often necessary to relieve bothersome urinary symptoms, these procedures are associated with an increased risk of sexual dysfunction.</strong></span> <span style="color: rgb(44, 130, 201)"><strong>As such, there has been an increased interest in the development of minimally invasive therapies, such as the </strong></span><span style="color: rgb(250, 197, 28)"><strong>UroLift®, Rezum®, and Aquablation®, </strong></span><span style="color: rgb(44, 130, 201)"><strong>with the hopes of achieving similar symptomatic relief while maintaining sexual function. Aside from reporting lower rates of sexual dysfunction, these procedures have also demonstrated comparable safety, durability, and efficacy to current gold standard therapies. </strong></span>Some procedures can even be performed in an outpatient setting, avoiding the need for general anesthesia altogether. Overall, an individualized, shared decision-making approach is necessary to determine the ideal treatment option for each patient.</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong>Conclusions </strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><strong>There has recently been a multitude of innovative surgical technologies for the treatment of BPH and LUTS.</strong></span> <span style="color: rgb(250, 197, 28)"><strong>TURP remains the gold standard for the treatment of BPH but is associated with high rates of EjD. Thus, patients should be counseled appropriately regarding the potential reduction in postoperative sexual function. </strong></span><span style="color: rgb(44, 130, 201)"><strong>Minimally invasive procedures should also be discussed as an alternative, especially in patients who wish to preserve their sexual function. These novel technologies are a promising option to patients and have demonstrated safe, effective, and durable cure to treating BPH symptoms while minimizing sexual dysfunction. </strong></span><strong>Ultimately, as the robust and dynamic field of BPH treatment continues to grow and advance, an individualized, shared decision-making approach among physicians and their patients should be undertaken to select the optimal treatment option for each patient. Regardless of the outcome of the procedure, providers should always be ready to support and assist patients in their journey to recovery. </strong></p></blockquote><p></p>
[QUOTE="madman, post: 157711, member: 13851"] [B][COLOR=rgb(184, 49, 47)]Abstract [/COLOR][/B] [B]Purpose of Review [/B] To review the prevalence and risks of sexual dysfunction associated with current treatment options for benign prostatic hyperplasia and to characterize techniques and methods to manage postoperative sexual dysfunction related side effects. [B]Recent Findings [/B] Current surgical therapies available for the treatment of benign prostatic hyperplasia are associated with a substantial risk of both ejaculatory and erectile function. However, many of the novel minimally invasive treatment alternatives have demonstrated the ability to preserve postoperative sexual function to a better degree, all while providing significant relief of lower urinary tract symptoms in an equally safe and efficacious manner. [B]Summary [/B] [COLOR=rgb(184, 49, 47)][B]Benign prostatic hyperplasia remains a highly prevalent disease among the aging population. While surgical treatments are often necessary to relieve bothersome urinary symptoms, these procedures are associated with an increased risk of sexual dysfunction.[/B][/COLOR] [COLOR=rgb(44, 130, 201)][B]As such, there has been an increased interest in the development of minimally invasive therapies, such as the [/B][/COLOR][COLOR=rgb(250, 197, 28)][B]UroLift®, Rezum®, and Aquablation®, [/B][/COLOR][COLOR=rgb(44, 130, 201)][B]with the hopes of achieving similar symptomatic relief while maintaining sexual function. Aside from reporting lower rates of sexual dysfunction, these procedures have also demonstrated comparable safety, durability, and efficacy to current gold standard therapies. [/B][/COLOR]Some procedures can even be performed in an outpatient setting, avoiding the need for general anesthesia altogether. Overall, an individualized, shared decision-making approach is necessary to determine the ideal treatment option for each patient. [B]Conclusions [/B] [COLOR=rgb(184, 49, 47)][B]There has recently been a multitude of innovative surgical technologies for the treatment of BPH and LUTS.[/B][/COLOR] [COLOR=rgb(250, 197, 28)][B]TURP remains the gold standard for the treatment of BPH but is associated with high rates of EjD. Thus, patients should be counseled appropriately regarding the potential reduction in postoperative sexual function. [/B][/COLOR][COLOR=rgb(44, 130, 201)][B]Minimally invasive procedures should also be discussed as an alternative, especially in patients who wish to preserve their sexual function. These novel technologies are a promising option to patients and have demonstrated safe, effective, and durable cure to treating BPH symptoms while minimizing sexual dysfunction. [/B][/COLOR][B]Ultimately, as the robust and dynamic field of BPH treatment continues to grow and advance, an individualized, shared decision-making approach among physicians and their patients should be undertaken to select the optimal treatment option for each patient. Regardless of the outcome of the procedure, providers should always be ready to support and assist patients in their journey to recovery. [/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Avoiding Sexual Dysfunction in BPH Surgery
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top